Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Digital health software and connected health technology / Remote monitoring, digital therapeutics and connected-care technology / Payer-sponsored remote-care benefit and program delivery

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Payer-sponsored remote-care benefit and program delivery

For payers that need to manage member health, coordinate remote care, and connect benefits to clinical workflows, particularly when avoidable utilization, chronic-disease costs, member engagement, or network performance trigger investment in payer-owned or payer-sponsored remote monitoring, digital therapeutics, and connected-care services. Excludes technology purchased directly by providers or pharmaceutical companies.

Market size
—
Not sized yet
Growth
—
CAGR
Attractiveness
85 /100
for B2B sellers
Evidence
not sized
2 sources · no estimate
Level
Niche
Segmented by
Customer type
Buyers
Health insurers and other payers
Buying centre
The chief medical officer, medical management, network operations, care management, and member engagement lead clinical sponsorship. Actuarial, finance, utilization management, IT, information security, data governance, legal, procurement, and contracted provider networks influence selection and con
Buying triggers
  • Rising avoidable utilization or cost of care
  • Chronic-disease and post-acute care management priorities
  • Pressure to improve member engagement and retention
  • Need for measurable outcomes from provider-delivered connected-care programs
Pains
  • Difficulty demonstrating utilization and outcome impact
  • Fragmentation across member, provider, and vendor systems
  • Low member activation or adherence
  • Complexity of contracting with providers while protecting data and budgets
Scores (1–5)
Pain intensity4
Purchasing power5
Reachability4
Growth4

How this was sized

Not sized yet

The cited sources report broad connected-healthcare market totals—for example USD 108.60B in 2026—but do not disclose payer-funded revenue or a payer share [6]. A separate source estimates USD 105.48B for 2026 and a 20.55% CAGR for 2026-2031, demonstrating that broad-market estimates vary by scope and are not a payer-specific proxy [8]. Scores use a 1-5 scale, with 5 highest.

Alongside it in Remote monitoring, digital therapeutics and connected-care technology

// Sell into Payer-sponsored remote-care benefit and program delivery

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.